JOE
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Journal of Endocrinology (1999) 161, 299-306       DOI: 10.1677/joe.0.1610299
© 1999 Society for Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (17)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Denison, F.
Right arrow Articles by Riley, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Denison, F.
Right arrow Articles by Riley, S.
Journal of Endocrinology, Vol 161, Issue 2, 299-306
Copyright © 1999 by Society for Endocrinology

Articles

Secretory leukocyte protease inhibitor concentration increases in amniotic fluid with the onset of labour in women: characterization of sites of release within the uterus

FC Denison, RW Kelly, AA Calder, and SC Riley


Secretory leukocyte protease inhibitor is a potent inhibitor of neutrophil function, a mediator of mucosal immunity and an inhibitor of NF|gkB regulated inflammatory responses. However, its source, function and regulation within the uterus during pregnancy and at parturition are not well defined. In amniotic fluid, the concentration of secretory leukocyte protease inhibitor increased significantly from 2nd trimester (24+/-3 ng/ml; mean+/-s.e.m.; n=20) to term (751+/-53 ng/ml; P<0.05; n=15) with a further profound increase (P<0.005) with the onset of labour (3929+/-1076 ng/ml; n=15). To establish the intra-uterine sites of secretion, explants (n=6 different patients per tissue) were collected at term after elective caesarean section. High levels of secretory leukocyte protease inhibitor were released by decidua (135.2+/-12.4 pg/mg; mean+/-s.e.m.) and chorio-decidua (325.1+/-26.4 pg/mg) with less by amnion (55.6+/-6.0 pg/mg) and placenta (9.2+/-1.9 pg/mg). Intense immunoreactivity for secretory leukocyte protease inhibitor was detected predominantly in decidua parietalis cells adherent to the chorion laeve and myometrium, and also in decidua basalis. We propose that, within the pregnant uterus, secretory leukocyte protease inhibitor is released by decidua, fetal membranes and potentially the fetal lung. The increase in secretory leukocyte protease inhibitor may act to modulate pro-inflammatory paracrine interactions for the maintenance of pregnancy and limit those occurring at parturition within the uterus.


This article has been cited by other articles:


Home page
 ReproductionHome page
A. W Horne, S. J Stock, and A. E King
Innate immunity and disorders of the female reproductive tract
Reproduction, June 1, 2008; 135(6): 739 - 749.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
L. Ming, P. Xiaoling, L. Yan, W. Lili, W. Qi, Y. Xiyong, W. Boyao, and H. Ning
Purification of antimicrobial factors from human cervical mucus
Hum. Reprod., July 1, 2007; 22(7): 1810 - 1815.
[Abstract] [Full Text] [PDF]

Home page
 Integr. Comp. Biol.Home page
J. V. Fahey, T. M. Schaefer, and C. R. Wira
Sex hormone modulation of human uterine epithelial cell immune responses
Integr. Comp. Biol., December 1, 2006; 46(6): 1082 - 1087.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
M C Velarde, S I Parisek, R R Eason, F A Simmen, and R C M Simmen
The secretory leukocyte protease inhibitor gene is a target of epidermal growth factor receptor action in endometrial epithelial cells
J. Endocrinol., January 1, 2005; 184(1): 141 - 151.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
Y. Ota, K. Shimoya, Q. Zhang, A. Moriyama, R. Chin, K. Tenma, T. Kimura, M. Koyama, C. Azuma, and Y. Murata
The expression of secretory leukocyte protease inhibitor (SLPI) in the Fallopian tube: SLPI protects the acrosome reaction of sperm from inhibitory effects of elastase
Hum. Reprod., October 1, 2002; 17(10): 2517 - 2522.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. Zhang, R. C. M. Simmen, F. J. Michel, G. Zhao, D. Vale-Cruz, and F. A. Simmen
Secretory Leukocyte Protease Inhibitor Mediates Proliferation of Human Endometrial Epithelial Cells by Positive and Negative Regulation of Growth-associated Genes
J. Biol. Chem., August 9, 2002; 277(33): 29999 - 30009.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
A. E. King, D. C. Fleming, H. O.D. Critchley, and R. W. Kelly
Regulation of natural antibiotic expression by inflammatory mediators and mimics of infection in human endometrial epithelial cells
Mol. Hum. Reprod., April 1, 2002; 8(4): 341 - 349.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
K.W. Marvin, J.A. Keelan, R.L. Eykholt, T.A. Sato, and M.D. Mitchell
Use of cDNA arrays to generate differential expression profiles for inflammatory genes in human gestational membranes delivered at term and preterm
Mol. Hum. Reprod., April 1, 2002; 8(4): 399 - 408.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
Q. Zhang, K. Shimoya, A. Moriyama, K. Yamanaka, A. Nakajima, T. Nobunaga, M. Koyama, C. Azuma, and Y. Murata
Production of secretory leukocyte protease inhibitor by human amniotic membranes and regulation of its concentration in amniotic fluid
Mol. Hum. Reprod., June 1, 2001; 7(6): 573 - 579.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
A. E. King, H. O.D. Critchley, and R. W. Kelly
Presence of secretory leukocyte protease inhibitor in human endometrium and first trimester decidua suggests an antibacterial protective role
Mol. Hum. Reprod., February 1, 2000; 6(2): 191 - 196.
[Abstract] [Full Text] [PDF]


HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the Society for Endocrinology.